Athenex Presents Interim Data from ANCHOR Study of KUR-502 (Allogeneic CD19 CAR-NKT Cells) in Relapsed or Refractory Lymphoma and Leukemia at 63rd ASH Annual Meeting and Exposition

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Daniel Sontupe
Market Access

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement